Petra Herzig
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 5%
- T-cell and B-cell Immunology
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 16
-
- Immune Cell Function and Interaction 3
- Immune cells in cancer 1
- Co-authors
- Alfred Zippelius (19 shared papers)Daniela S. Thommen (7 shared papers)Didier Lardinois (11 shared papers)Andreas Roller (3 shared papers)Christian Klein (4 shared papers)Vaios Karanikas (3 shared papers)Spasenija Savic Prince (3 shared papers)Ton N. Schumacher (3 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (5 papers)Nature Medicine (2 papers)Nature Communications (2 papers)OncoImmunology (2 papers)Cancer Immunology Research (2 papers)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Petra Herzig
22 papers receiving 2.2k citations
Petra Herzig's Hit Papers
Peers
Comparison fields: 5 of 49
- Oncology 1.3k
- Immunology 214
- Cancer Research 27
- Genetics 19
- Otorhinolaryngology 11
Countries citing papers authored by Petra Herzig
This map shows the geographic impact of Petra Herzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Herzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Herzig more than expected).
Fields of papers citing papers by Petra Herzig
This network shows the impact of papers produced by Petra Herzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Herzig. The network helps show where Petra Herzig may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Herzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade Hit paper breakdown → | 2018 | 928 |
| 2 | 2015 | 342 | |
| 3 | An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer Hit paper breakdown → | 2021 | 284 |
| 4 | 2015 | 120 | |
| 5 | 2020 | 72 | |
| 6 | 2017 | 70 | |
| 7 | 2023 | 70 | |
| 8 | 2020 | 50 | |
| 9 | 2019 | 44 | |
| 10 | 2015 | 42 | |
| 11 | 2019 | 37 | |
| 12 | 2021 | 35 | |
| 13 | 2015 | 30 | |
| 14 | 2024 | 29 | |
| 15 | 2022 | 20 | |
| 16 | 2023 | 16 | |
| 17 | 2019 | 10 | |
| 18 | 2025 | 5 | |
| 19 | 2016 | 4 | |
| 20 | 2021 | 4 |
About Petra Herzig
Petra Herzig is a scholar working on Oncology, Immunology, Molecular Biology, Surgery and Nuclear Energy and Engineering, having authored 28 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), Immune Cell Function and Interaction (3 papers), Enzyme function and inhibition (2 papers), Glycosylation and Glycoproteins Research (2 papers), Bladder and Urothelial Cancer Treatments (1 paper) and Immune cells in cancer (1 paper). The work is most often cited by research in Oncology (1.3k citations), Immunology (214 citations), Cancer Research (27 citations), Genetics (19 citations) and Otorhinolaryngology (11 citations). Petra Herzig has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Alfred Zippelius, Daniela S. Thommen, Didier Lardinois, Andreas Roller, Christian Klein, Vaios Karanikas, Spasenija Savic Prince, Ton N. Schumacher, Mark Nikolaj Wiese and Viktor Hendrik Koelzer. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Nature Medicine, Nature Communications, OncoImmunology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.